#new subgroup analysis shows

Collection of new subgroup analysis shows news, found 1 news.

New subgroup analysis shows Asian non-small cell lung cancer patients with most common EGFR mutation (del19) lived significantly longer with first-line GIOTRIF® (afatinib*) compared to chemotherapy

New subgroup analysis shows Asian non-small cell lung cancer patients with most common EGFR mutation (del19) lived significantly longer with first-line GIOTRIF® (afatinib*) compared to chemotherapy

  • 7th November 2014

- For Media In Asian Countries Only For Whom The Data Is Relevant (For media outside UK, US and Canada only)Boehringer ...